Literature DB >> 11309315

Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.

A Menke1, C Philippi, R Vogelmann, B Seidel, M P Lutz, G Adler, D Wedlich.   

Abstract

E-cadherin-mediated cell-cell adhesion is reduced in epithelial tumors, which is thought to be a prerequisite to acquire invasive properties. We observed that several pancreatic carcinoma cell lines with high metastatic potential expressed normal levels of E-cadherin and possessed functional E-cadherin/catenin adhesion complexes. When the cell lines PANC-1, BxPC-3, and PaTu8988s were cultured either on type I or type III collagen, E-cadherin gene expression was repressed, and E-cadherin and catenin protein concentrations were reduced. In contrast, growth on fibronectin and collagen type IV had no influence. Collagen type I- or type III-dependent reduction of E-cadherin expression led to decreased cell-cell adhesion, increased proliferation, and migratory activity as well as morphological transformation. Overexpression of activated c-Src in PANC-1 cells mimicked collagen-induced E-cadherin down-regulation and changed the elevated cell proliferation and migration. Conversely, treatment of cells with the Src-inhibitors PP1 or herbimycin A resulted in complete suppression of collagen type I-induced E-cadherin decrease. Our data demonstrate that specific collagens are able to promote metastatic behavior by down-regulation of E-cadherin gene expression in a Src-kinase-dependent manner. This points toward a novel mechanism for substrate-dependent signaling and underlines the significance of extracellular matrix environment for tumor growth and invasiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309315

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

1.  Phosphoinositide-3 kinase-Rac1-c-Jun NH2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells.

Authors:  Yasushi Shintani; Margaret J Wheelock; Keith R Johnson
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

2.  Knockdown of the β(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis.

Authors:  John J Grzesiak; Hop S Tran Cao; Douglas W Burton; Sharmeela Kaushal; Fabian Vargas; Paul Clopton; Cynthia S Snyder; Leonard J Deftos; Robert M Hoffman; Michael Bouvet
Journal:  Int J Cancer       Date:  2011-04-13       Impact factor: 7.396

3.  Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Cheryl Chalberg; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 4.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.

Authors:  Megumi Iiizumi; Wen Liu; Sudha K Pai; Eiji Furuta; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2008-07-22

5.  ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin.

Authors:  Tiansuo Zhao; Wenna Jiang; Xiuchao Wang; Hongwei Wang; Chen Zheng; Yang Li; Yan Sun; Chongbiao Huang; Zhi-Bo Han; Shengyu Yang; Zhiliang Jia; Keping Xie; He Ren; Jihui Hao
Journal:  Cancer Res       Date:  2016-12-06       Impact factor: 12.701

6.  Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.

Authors:  Lucas DeMaio; Stephen T Buckley; Manda S Krishnaveni; Per Flodby; Mickael Dubourd; Agnes Banfalvi; Yiming Xing; Carsten Ehrhardt; Parviz Minoo; Beiyun Zhou; Edward D Crandall; Zea Borok
Journal:  J Pathol       Date:  2011-12-09       Impact factor: 7.996

7.  A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors.

Authors:  Niharika B Mettu; Donna Niedzwiecki; Christel Rushing; Andrew B Nixon; Jingquan Jia; Sherri Haley; Wanda Honeycutt; Herbert Hurwitz; Johanna C Bendell; Hope Uronis
Journal:  Cancer Chemother Pharmacol       Date:  2019-03-20       Impact factor: 3.333

Review 8.  Extracellular Matrix Scaffold Technology for Bioartificial Pancreas Engineering: State of the Art and Future Challenges.

Authors:  Marcus Salvatori; Ravi Katari; Timil Patel; Andrea Peloso; Jon Mugweru; Kofi Owusu; Giuseppe Orlando
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

9.  Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor.

Authors:  David Domínguez; Bàrbara Montserrat-Sentís; Ariadna Virgós-Soler; Sandra Guaita; Judit Grueso; Montserrat Porta; Isabel Puig; Josep Baulida; Clara Francí; Antonio García de Herreros
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1.

Authors:  Damian Medici; Ali Nawshad
Journal:  Matrix Biol       Date:  2009-12-16       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.